Back to Authors

Pressman, Peter S

Mayo Clinic

From the VIB Center for Molecular Neurology (M.V., R.R., V.B., S.W.); Department of Biomedical Sciences (M.V., M.V.B., S.W., R.R.), University of Antwerp, Belgium; Department of Neurology (E.M.R., M.F.M.), David Geffen School of Medicine, University of Cal

Citations 3

Antiamyloid Monoclonal Antibodies in Alzheimer’s Disease, Part 2: Challenges in Dementia Care Delivery System Logistics

The Journal of Neuropsychiatry and Clinical Neurosciences | June 26, 2025 | Volume: 37 | Issue: 4 | Pages: 378-384

10.1176/appi.neuropsych.20240203 | PMID 40566858

Antiamyloid Monoclonal Antibodies in Alzheimer’s Disease, Part 1: Patient Selection

The Journal of Neuropsychiatry and Clinical Neurosciences | May 5, 2025 | Volume: 37 | Issue: 4 | Pages: 371-377

10.1176/appi.neuropsych.20240191 | PMID 40320852

Gene-Specific Effects on Brain Volume and Cognition of TMEM106B in Frontotemporal Lobar Degeneration

Neurology | September 25, 2024 | Volume: 103 | Issue: 8 | Pages: No page available

10.1212/wnl.0000000000209832 | PMID 39321401